Literature DB >> 9135528

Stimulation of beta-adrenoceptors with isoprenaline inhibits small intestinal activity fronts and induces a postprandial-like motility pattern in humans.

M Thollander1, T H Svensson, P M Hellström.   

Abstract

AIMS: To investigate the effects of beta-adrenoceptor stimulation, using the agonist isoprenaline and the antagonist propranolol, on migrating motor complexes in the upper intestine of 16 healthy human volunteers.
METHODS: Fasting motility was monitored using a tube with water perfused side holes connected to a pneumohydraulic system. Continuous eight hour recordings were obtained from each volunteer after a 12 hour fasting period. In all experiments, saline was given as control for the first four hour period and beta-adrenergic agents for the next four hours. In separate control studies, saline was given for the whole eight hour period.
RESULTS: Isoprenaline (2.5 micrograms/kg/min) reduced the number of activity fronts (phase III) of migrating motor complexes from 3 (2-4) in controls to 1 (0-2) during isoprenaline infusion (p < 0.01). Also, phase II-like activity replaced the regular motility pattern (p < 0.01). By contrast, propranolol (25 micrograms/kg/min) did not induce any significant changes in phase III compared with controls. Saline alone had no effect on motor activity.
CONCLUSIONS: Isoprenaline inhibited activity fronts in the human proximal small intestine and induced a postprandial-like motility pattern, whereas propranolol did not affect motor patterns. Stimulation of beta-adrenoceptors is of importance in the control of motor activity of the human small intestine, especially under stressful conditions with high adrenergic activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135528      PMCID: PMC1027089          DOI: 10.1136/gut.40.3.376

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

1.  The site and receptors responsible for the inhibition by sympathetic nerves of intestinal smooth muscle and its parasympathetic motor nerves.

Authors:  J S Gillespie; M A Khoyi
Journal:  J Physiol       Date:  1977-06       Impact factor: 5.182

2.  [Subacute sclerosing panencephalitis (SSPE) in Poland in the years 1993-1995. The sixth stage of epidemiological research].

Authors:  D Naruszewicz-Lesiuk; B Iwińska-Buksowioz; M Wieczorkiewicz; J Kulczycki; W Gut
Journal:  Przegl Epidemiol       Date:  1997

3.  Sympathetic control of motility, fluid transport, and transmural potential difference in the rabbit ileum.

Authors:  B Greenwood; L Tremblay; J S Davison
Journal:  Am J Physiol       Date:  1987-12

4.  Beta-adrenergic control of motility in the rat colon. I. Evidence for functional separation of the beta 1- and beta 2-adrenoceptor-mediated inhibition of colon activity.

Authors:  B A Ek; L A Bjellin; B T Lundgren
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

5.  Activity fronts in fed dogs: effect of a beta-adrenergic agonist.

Authors:  R Yanda; R W Summers
Journal:  Am J Physiol       Date:  1983-11

6.  Analysis of the role of adrenergic receptors in the regulation of small intestine motor activity in sheep.

Authors:  Z Leroch; T Wegrzyn; D Zieba; S Gutowski; J Debowy
Journal:  Acta Physiol Pol       Date:  1983 Mar-Apr

7.  Characterization of the beta-adrenergic inhibition of motility in cat colon strips.

Authors:  B Ek; B Lundgren
Journal:  Eur J Pharmacol       Date:  1982-01-08       Impact factor: 4.432

8.  Modulation of human upper intestinal nutrient transit by a beta adrenoreceptor mediated pathway.

Authors:  A S McIntyre; D G Thompson; S Day; W R Burnham; E R Walker
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

9.  Effects of beta-adrenoceptor blocking drugs on human sigmoid colonic motility.

Authors:  H Abrahamsson; E Lyrenäs; G Dotevall
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

10.  Role of alpha-2 adrenergic receptors in the control of diarrhea and intestinal motility.

Authors:  N S Doherty; A A Hancock
Journal:  J Pharmacol Exp Ther       Date:  1983-05       Impact factor: 4.030

View more
  1 in total

1.  Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.

Authors:  Nilaksh Gupta; Jennifer A Buffa; Adam B Roberts; Naseer Sangwan; Sarah M Skye; Lin Li; Karen J Ho; John Varga; Joseph A DiDonato; W H Wilson Tang; Stanley L Hazen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-26       Impact factor: 8.311

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.